Prostate Cancer Medicine Market - Industry Analysis, Market Size, Share, Trends, Application Analysis, Growth And Forecast 2019 - 2024

Report Code: HCR 28127 Report Format: PDF + Excel (Delivery in 48 Hrs)
1. Prostate Cancer Medicine Market - Overview
        1.1 Definitions and Scope
2. Prostate Cancer Medicine Market - Executive summary
        2.1 Market Revenue, Market Size and Key Trends by Company
        2.2 Key Trends by type of Application
        2.3 Key Trends segmented by Geography
3. Prostate Cancer Medicine Market
        3.1 Comparative analysis
            3.1.1 Product Benchmarking - Top 10 companies
            3.1.2 Top 5 Financials Analysis
            3.1.3 Market Value split by Top 10 companies
            3.1.4 Patent Analysis - Top 10 companies
            3.1.5 Pricing Analysis
4. Prostate Cancer Medicine Market - Startup companies Scenario Premium
        4.1 Top 10 startup company Analysis by
            4.1.1 Investment
            4.1.2 Revenue
            4.1.3 Market Shares
            4.1.4 Market Size and Application Analysis
            4.1.5 Venture Capital and Funding Scenario
5. Prostate Cancer Medicine Market - Industry Market Entry Scenario Premium
        5.1 Regulatory Framework Overview
        5.2 New Business and Ease of Doing business index
        5.3 Case studies of successful ventures
        5.4 Customer Analysis - Top 10 companies
6. Prostate Cancer Medicine Market Forces
        6.1 Drivers
        6.2 Constraints
        6.3 Challenges
        6.4 Porters five force model
            6.4.1 Bargaining power of suppliers
            6.4.2 Bargaining powers of customers
            6.4.3 Threat of new entrants
            6.4.4 Rivalry among existing players
            6.4.5 Threat of substitutes
7. Prostate Cancer Medicine Market -Strategic analysis
        7.1 Value chain analysis
        7.2 Opportunities analysis
        7.3 Product life cycle
        7.4 Suppliers and distributors Market Share
8. Prostate Cancer Medicine Market - By Product (Market Size -$Million / $Billion)
        8.1 Market Size and Market Share Analysis
        8.2 Application Revenue and Trend Research
        8.3 Product Segment Analysis
9. Prostate Cancer Medicine Market - By Drug Type (Market Size -$Million / $Billion)
        9.1 Hormonal Therapy Drug
           9.1.1 Lhrh Antagonist
           9.1.2 Lhrh Analog
           9.1.3 Antiandrogens
           9.1.4 Pipeline Drug For Hormonal Therapy
        9.2 Chemotherapy Drug
           9.2.1 Off Patent Drug
           9.2.2 Patented Drug
        9.3 Immunotherapy Drug
        9.4 Target Therapy Drug
           9.4.1 Angiogenesis Inhibitor
           9.4.2 Apoptosis Inducing
           9.4.3 Signal Transduction Inhibitor
10. Prostate Cancer Medicine - By Application (Market Size -$Million / $Billion)
        10.1 Segment type Size and Market Share Analysis
        10.2 Application Revenue and Trends by type of Application
        10.3 Application Segment Analysis by Type
11. Prostate Cancer Medicine- By Geography (Market Size -$Million / $Billion)
        11.1 Prostate Cancer Medicine Market - North America Segment Research
        11.2 North America Market Research (Million / $Billion)
            11.2.1 Segment type Size and Market Size Analysis
            11.2.2 Revenue and Trends
            11.2.3 Application Revenue and Trends by type of Application
            11.2.4 Company Revenue and Product Analysis
            11.2.5 North America Product type and Application Market Size
                  11.2.5.1 U.S
                  11.2.5.2 Canada
                  11.2.5.3 Mexico
                  11.2.5.4 Rest of North America
        11.3 Prostate Cancer Medicine- South America Segment Research
        11.4 South America Market Research (Market Size -$Million / $Billion)
            11.4.1 Segment type Size and Market Size Analysis
            11.4.2 Revenue and Trends
            11.4.3 Application Revenue and Trends by type of Application
            11.4.4 Company Revenue and Product Analysis
            11.4.5 South America Product type and Application Market Size
                  11.4.5.1 Brazil
                  11.4.5.2 Venezuela
                  11.4.5.3 Argentina
                  11.4.5.4 Ecuador
                  11.4.5.5 Peru
                  11.4.5.6 Colombia
                  11.4.5.7 Costa Rica
                  11.4.5.8 Rest of South America
        11.5 Prostate Cancer Medicine- Europe Segment Research
        11.6 Europe Market Research (Market Size -$Million / $Billion)
            11.6.1 Segment type Size and Market Size Analysis
            11.6.2 Revenue and Trends
            11.6.3 Application Revenue and Trends by type of Application
            11.6.4 Company Revenue and Product Analysis
            11.6.5 Europe Segment Product type and Application Market Size
                  11.6.5.1 U.K
                  11.6.5.2 Germany
                  11.6.5.3 Italy
                  11.6.5.4 France
                  11.6.5.5 Netherlands
                  11.6.5.6 Belgium
                  11.6.5.7 Denmark
                  11.6.5.8 Spain
                  11.6.5.9 Rest of Europe
        11.7 Prostate Cancer Medicine - APAC Segment Research
        11.8 APAC Market Research (Market Size -$Million / $Billion)
            11.8.1 Segment type Size and Market Size Analysis
            11.8.2 Revenue and Trends
            11.8.3 Application Revenue and Trends by type of Application
            11.8.4 Company Revenue and Product Analysis
            11.8.5 APAC Segment - Product type and Application Market Size
                  11.8.5.1 China
                  11.8.5.2 Australia
                  11.8.5.3 Japan
                  11.8.5.4 South Korea
                  11.8.5.5 India
                  11.8.5.6 Taiwan
                  11.8.5.7 Malaysia
                  11.8.5.8 Hong kong
                  11.8.5.9 Rest of APAC
        11.9 Prostate Cancer Medicine - Middle East Segment and Africa Segment Research
        11.10 Middle East & Africa Market Research (Market Size -$Million / $Billion)
            11.10.1 Segment type Size and Market Size Analysis
            11.10.2 Revenue and Trend Analysis
            11.10.3 Application Revenue and Trends by type of Application
            11.10.4 Company Revenue and Product Analysis
            11.10.5 Middle East Segment Product type and Application Market Size
                  11.10.5.1 Israel
                  11.10.5.2 Saudi Arabia
                  11.10.5.3 UAE
            11.10.6 Africa Segment Analysis
                  11.10.6.1 South Africa
                  11.10.6.2 Rest of Middle East & Africa
12. Prostate Cancer Medicine Market - Entropy
        12.1 New product launches
        12.2 M&A s, collaborations, JVs and partnerships
13. Prostate Cancer Medicine Market - Industry / Segment Competition landscape Premium
        13.1 Market Share Analysis
            13.1.1 Market Share by Country- Top companies
            13.1.2 Market Share by Region- Top 10 companies
            13.1.3 Market Share by type of Application - Top 10 companies
            13.1.4 Market Share by type of Product / Product category- Top 10 companies
            13.1.5 Market Share at global level - Top 10 companies
            13.1.6 Best Practises for companies
14. Prostate Cancer Medicine Market - Key Company List by Country Premium
15. Prostate Cancer Medicine Market Company Analysis
        15.1 Market Share, Company Revenue, Products, M&A, Developments
        15.2 Abbott Laboratory
        15.3 Active Biotech
        15.4 Astellas Pharma Inc
        15.5 Astrazeneca Plc
        15.6 Bayer Ag
        15.7 Bristol Myers-Squibb
        15.8 Johnson Johnson
        15.9 Pfizer Inc
        15.10 Roche Holding Ag
        15.11 Teva Pharmaceutical Industry Ltd
        15.12 Company 12
        15.13 Company 13 & More
*Financials would be provided on a best efforts basis for private companies
16. Prostate Cancer Medicine Market - Appendix
        16.1 Abbreviations
        16.2 Sources
17. Prostate Cancer Medicine Market - Methodology
        17.1 Research Methodology
            17.1.1 Company Expert Interviews
            17.1.2 Industry Databases
            17.1.3 Associations
            17.1.4 Company News
            17.1.5 Company Annual Reports
            17.1.6 Application Trends
            17.1.7 New Products and Product database
            17.1.8 Company Transcripts
            17.1.9 R&D Trends
            17.1.10 Key Opinion Leaders Interviews
            17.1.11 Supply and Demand Trends

LIST OF TABLES

1.Global Prostate Cancer Medicine Market, By Drug Type Market 2019-2024 ($M)
1.1 Hormonal Therapy Drug Market 2019-2024 ($M) - Global Industry Research
1.1.1 Lhrh Antagonist Market 2019-2024 ($M)
1.1.2 Lhrh Analog Market 2019-2024 ($M)
1.1.3 Antiandrogens Market 2019-2024 ($M)
1.1.4 Pipeline Drug For Hormonal Therapy Market 2019-2024 ($M)
1.4 Target Therapy Drug Market 2019-2024 ($M) - Global Industry Research
1.4.1 Angiogenesis Inhibitor Market 2019-2024 ($M)
1.4.2 Apoptosis Inducing Market 2019-2024 ($M)
1.4.3 Signal Transduction Inhibitor Market 2019-2024 ($M)
2.Global Prostate Cancer Medicine Market, By Drug Type Market 2019-2024 (Volume/Units)
2.1 Hormonal Therapy Drug Market 2019-2024 (Volume/Units) - Global Industry Research
2.1.1 Lhrh Antagonist Market 2019-2024 (Volume/Units)
2.1.2 Lhrh Analog Market 2019-2024 (Volume/Units)
2.1.3 Antiandrogens Market 2019-2024 (Volume/Units)
2.1.4 Pipeline Drug For Hormonal Therapy Market 2019-2024 (Volume/Units)
2.4 Target Therapy Drug Market 2019-2024 (Volume/Units) - Global Industry Research
2.4.1 Angiogenesis Inhibitor Market 2019-2024 (Volume/Units)
2.4.2 Apoptosis Inducing Market 2019-2024 (Volume/Units)
2.4.3 Signal Transduction Inhibitor Market 2019-2024 (Volume/Units)
3.North America Prostate Cancer Medicine Market, By Drug Type Market 2019-2024 ($M)
3.1 Hormonal Therapy Drug Market 2019-2024 ($M) - Regional Industry Research
3.1.1 Lhrh Antagonist Market 2019-2024 ($M)
3.1.2 Lhrh Analog Market 2019-2024 ($M)
3.1.3 Antiandrogens Market 2019-2024 ($M)
3.1.4 Pipeline Drug For Hormonal Therapy Market 2019-2024 ($M)
3.4 Target Therapy Drug Market 2019-2024 ($M) - Regional Industry Research
3.4.1 Angiogenesis Inhibitor Market 2019-2024 ($M)
3.4.2 Apoptosis Inducing Market 2019-2024 ($M)
3.4.3 Signal Transduction Inhibitor Market 2019-2024 ($M)
4.South America Prostate Cancer Medicine Market, By Drug Type Market 2019-2024 ($M)
4.1 Hormonal Therapy Drug Market 2019-2024 ($M) - Regional Industry Research
4.1.1 Lhrh Antagonist Market 2019-2024 ($M)
4.1.2 Lhrh Analog Market 2019-2024 ($M)
4.1.3 Antiandrogens Market 2019-2024 ($M)
4.1.4 Pipeline Drug For Hormonal Therapy Market 2019-2024 ($M)
4.4 Target Therapy Drug Market 2019-2024 ($M) - Regional Industry Research
4.4.1 Angiogenesis Inhibitor Market 2019-2024 ($M)
4.4.2 Apoptosis Inducing Market 2019-2024 ($M)
4.4.3 Signal Transduction Inhibitor Market 2019-2024 ($M)
5.Europe Prostate Cancer Medicine Market, By Drug Type Market 2019-2024 ($M)
5.1 Hormonal Therapy Drug Market 2019-2024 ($M) - Regional Industry Research
5.1.1 Lhrh Antagonist Market 2019-2024 ($M)
5.1.2 Lhrh Analog Market 2019-2024 ($M)
5.1.3 Antiandrogens Market 2019-2024 ($M)
5.1.4 Pipeline Drug For Hormonal Therapy Market 2019-2024 ($M)
5.4 Target Therapy Drug Market 2019-2024 ($M) - Regional Industry Research
5.4.1 Angiogenesis Inhibitor Market 2019-2024 ($M)
5.4.2 Apoptosis Inducing Market 2019-2024 ($M)
5.4.3 Signal Transduction Inhibitor Market 2019-2024 ($M)
6.APAC Prostate Cancer Medicine Market, By Drug Type Market 2019-2024 ($M)
6.1 Hormonal Therapy Drug Market 2019-2024 ($M) - Regional Industry Research
6.1.1 Lhrh Antagonist Market 2019-2024 ($M)
6.1.2 Lhrh Analog Market 2019-2024 ($M)
6.1.3 Antiandrogens Market 2019-2024 ($M)
6.1.4 Pipeline Drug For Hormonal Therapy Market 2019-2024 ($M)
6.4 Target Therapy Drug Market 2019-2024 ($M) - Regional Industry Research
6.4.1 Angiogenesis Inhibitor Market 2019-2024 ($M)
6.4.2 Apoptosis Inducing Market 2019-2024 ($M)
6.4.3 Signal Transduction Inhibitor Market 2019-2024 ($M)
7.MENA Prostate Cancer Medicine Market, By Drug Type Market 2019-2024 ($M)
7.1 Hormonal Therapy Drug Market 2019-2024 ($M) - Regional Industry Research
7.1.1 Lhrh Antagonist Market 2019-2024 ($M)
7.1.2 Lhrh Analog Market 2019-2024 ($M)
7.1.3 Antiandrogens Market 2019-2024 ($M)
7.1.4 Pipeline Drug For Hormonal Therapy Market 2019-2024 ($M)
7.4 Target Therapy Drug Market 2019-2024 ($M) - Regional Industry Research
7.4.1 Angiogenesis Inhibitor Market 2019-2024 ($M)
7.4.2 Apoptosis Inducing Market 2019-2024 ($M)
7.4.3 Signal Transduction Inhibitor Market 2019-2024 ($M)

LIST OF FIGURES

1.US Prostate Cancer Medicine Market Revenue, 2019-2024 ($M)
2.Canada Prostate Cancer Medicine Market Revenue, 2019-2024 ($M)
3.Mexico Prostate Cancer Medicine Market Revenue, 2019-2024 ($M)
4.Brazil Prostate Cancer Medicine Market Revenue, 2019-2024 ($M)
5.Argentina Prostate Cancer Medicine Market Revenue, 2019-2024 ($M)
6.Peru Prostate Cancer Medicine Market Revenue, 2019-2024 ($M)
7.Colombia Prostate Cancer Medicine Market Revenue, 2019-2024 ($M)
8.Chile Prostate Cancer Medicine Market Revenue, 2019-2024 ($M)
9.Rest of South America Prostate Cancer Medicine Market Revenue, 2019-2024 ($M)
10.UK Prostate Cancer Medicine Market Revenue, 2019-2024 ($M)
11.Germany Prostate Cancer Medicine Market Revenue, 2019-2024 ($M)
12.France Prostate Cancer Medicine Market Revenue, 2019-2024 ($M)
13.Italy Prostate Cancer Medicine Market Revenue, 2019-2024 ($M)
14.Spain Prostate Cancer Medicine Market Revenue, 2019-2024 ($M)
15.Rest of Europe Prostate Cancer Medicine Market Revenue, 2019-2024 ($M)
16.China Prostate Cancer Medicine Market Revenue, 2019-2024 ($M)
17.India Prostate Cancer Medicine Market Revenue, 2019-2024 ($M)
18.Japan Prostate Cancer Medicine Market Revenue, 2019-2024 ($M)
19.South Korea Prostate Cancer Medicine Market Revenue, 2019-2024 ($M)
20.South Africa Prostate Cancer Medicine Market Revenue, 2019-2024 ($M)
21.North America Prostate Cancer Medicine By Application
22.South America Prostate Cancer Medicine By Application
23.Europe Prostate Cancer Medicine By Application
24.APAC Prostate Cancer Medicine By Application
25.MENA Prostate Cancer Medicine By Application
26.Astrazeneca Plc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
27.Active Biotech, Sales /Revenue, 2015-2018 ($Mn/$Bn)
28.Bristol Myers-Squibb, Sales /Revenue, 2015-2018 ($Mn/$Bn)
29.Teva Pharmaceutical Industry Ltd, Sales /Revenue, 2015-2018 ($Mn/$Bn)
30.Johnson Johnson, Sales /Revenue, 2015-2018 ($Mn/$Bn)
31.Pfizer Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
32.Bayer Ag, Sales /Revenue, 2015-2018 ($Mn/$Bn)
33.Abbott Laboratory, Sales /Revenue, 2015-2018 ($Mn/$Bn)
34.Astellas Pharma Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
35.Roche Holding Ag, Sales /Revenue, 2015-2018 ($Mn/$Bn)